-
effectivehealthcare.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1412.pdf
December 01, 2014 - Overall high-impact potential: Evzio for emergency treatment of opioid overdose by
nonclinicians .. … new (and new uses of existing) pharmaceuticals, medical
devices, diagnostic tests and procedures, therapeutic … purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs,
devices, procedures, treatments … , screening and diagnostics, therapeutics, surgery, programs, and
care delivery innovations that address … Medical
treatment would be expected to be sought after administration of Evzio.
-
effectivehealthcare.ahrq.gov/sites/default/files/10_obesity_potential_high_impact_june_2012.pdf
January 01, 2012 - new (and new uses of existing) pharmaceuticals, medical devices,
diagnostic tests and procedures, therapeutic … , screening and diagnostics, therapeutics, surgery, programs, and care delivery
innovations that address … (Contrave
®
, Orexigen Therapeutics, Inc., La Jolla, CA in
collaboration with Takeda Pharmaceutical … New drug treatment options are needed for
obese patients seeking medical therapy for weight loss. … Goods Administration for inclusion in its therapeutic goods registry for treating T2DM
and obesity
-
effectivehealthcare.ahrq.gov/sites/default/files/14_substance_abuse_potential_high_impact_2012-12-11.pdf
January 01, 2012 - new (and new uses of existing) pharmaceuticals, medical devices,
diagnostic tests and procedures, therapeutic … , screening and diagnostics, therapeutics, surgery, programs, and care
delivery innovations that address … intervention to these therapies to improve a patient’s chances of
successfully quitting. … in this report
would compete with shorter-acting oral, sublingual, injectable, or patch-delivered therapies … About buprenorphine therapy. [internet].
-
effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1306.pdf
June 01, 2013 - new (and new uses of existing) pharmaceuticals, medical devices,
diagnostic tests and procedures, therapeutic … , screening and diagnostics, therapeutics, surgery, programs, and care
delivery innovations that address … Key Facts: Before the approval of ivacaftor, therapies for CF had improved median survival
times … Better
treatments to prevent COPD exacerbations are needed. … Although the cost of azithromycin therapy would be
additive to current treatment costs, its low cost
-
effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1412.pdf
December 01, 2014 - new (and new uses of existing) pharmaceuticals, medical
devices, diagnostic tests and procedures, therapeutic … purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs,
devices, procedures, treatments … , screening and diagnostics, therapeutics, surgery, programs, and
care delivery innovations that address … 30% of patients achieve overall gout control, so a significant unmet need exists
for more effective treatments … could be more expensive than
existing options and patients who have trouble affording existing gout treatments
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0278_03-10-2008.pdf
January 01, 2008 - includes hand washing, in-hospital infection
control, appropriate antibiotic prescribing, and effective treatment … Date: 6-2-09
2
The literature on this topic indicates that large studies with more standardized treatment … regimens are
needed to evaluate the effectiveness of treatments for CDAD.
-
effectivehealthcare.ahrq.gov/sites/default/files/06_devdelays_autism_potential_high_impact_june_2012.pdf
January 01, 2012 - new (and new uses of existing) pharmaceuticals, medical devices,
diagnostic tests and procedures, therapeutic … , screening and diagnostics, therapeutics, surgery, programs, and care
delivery innovations that address … Treatment for early intervention includes behavioral and communication therapies (including
applied … archived from the horizon scanning system after
expert comment processes include hyperbaric oxygen therapy … However, the efficacy of these treatments is unpredictable and varies widely, and when
they do work
-
effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1412.pdf
December 01, 2014 - new (and new uses of existing) pharmaceuticals, medical
devices, diagnostic tests and procedures, therapeutic … , screening and diagnostics, therapeutics, surgery, programs, and
care delivery innovations that address … ulcerative colitis), and we
continue tracking novel drugs and interventions such as fecal microbiota therapy … No effective treatments are
available to improve long-term nutritional absorption other than intestinal … at-home intravenous PN support for
SBS, the manufacturer estimates the number of candidates for this therapy
-
effectivehealthcare.ahrq.gov/sites/default/files/depression_hi_impact.pdf
October 01, 2014 - , screening and diagnostics, therapeutics, surgery, programs, and care delivery
innovations that address … DBS therapy is incompatible with some other device-based depression
treatments. … psychotherapy
(e.g., counseling), and family intervention as indicated; and considering ECT or alternative therapies … , counseling, family intervention, ECT) will likely remain as
complementary therapies to ketamine, … New therapeutic promises
in the treatment of depression and
schizophrenia.
-
effectivehealthcare.ahrq.gov/sites/default/files/dementia-horizon-scan-high-impact-1412.pdf
February 01, 2015 - new (and new uses of existing) pharmaceuticals, medical
devices, diagnostic tests and procedures, therapeutic … , screening and diagnostics, therapeutics, surgery, programs, and
care delivery innovations that address … We have identified and
are currently monitoring multiple potential therapies with these properties, … Intranasal delivery
bypasses the blood-brain barrier to target
therapeutic agents to the central … Intranasal
insulin therapy for Alzheimer disease and
amnestic mild cognitive impairment: a pilot
-
effectivehealthcare.ahrq.gov/sites/default/files/05_depression_potential_high_impact_2012-12-10.pdf
January 01, 2012 - Overall high-impact potential: deep brain stimulation (Reclaim DBS Therapy or
Libra DBS) for treatment-resistant … and psychotherapy as first- and
second-line therapies and electroconvulsive therapy or repetitive … treatments for treatment-resistant
MDD, investigators have sought new approaches because available … DBS therapy is incompatible with some other device-based depression treatments. … Overall high-impact potential: deep brain stimulation (Reclaim DBS Therapy or Libra DBS)
for treatment-resistant
-
effectivehealthcare.ahrq.gov/sites/default/files/05_depression_potential_high_impact_june_2012.pdf
January 01, 2012 - Food and Drug Administration
has not approved any therapies, is being explored. … third-line therapies for MDD, a proportion of patients
affected by MDD have treatment-refractory disease … DBS therapy is incompatible with some other device-based depression treatments. … Menlo Park (CA):
Corcept Therapeutics; [accessed 2011 Oct 18].
[2 p]. … Menlo Park (CA): Corcept Therapeutics;
[accessed 2011 Oct 18]. [2 p].
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0283_03-10-2008.pdf
January 01, 2008 - interested in the
evidence base surrounding laparoscopic adjustable gastric banding (LAGB) for the
treatment … Many recent studies on the effectiveness of bariatric
surgery for the treatment of diabetes have shown … bariatric surgery to be more effective in treating type
2 diabetes than conventional therapy. … bariatric surgery,
such as a less invasive laparoscopic gastric banding, should be the first-line treatment
-
effectivehealthcare.ahrq.gov/sites/default/files/dementia-horizon-scan-high-impact-1312.pdf
December 01, 2013 - purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs,
devices, procedures, treatments … , screening and diagnostics, therapeutics, surgery, programs, and
care delivery innovations that address … Experts commenting on this intervention agreed that the need for disease-modifying treatments
for AD … Brain insulin resistance and
deficiency as therapeutic targets in Alzheimer's
disease. … Insulin: compare common
options for insulin therapy. [internet].
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-test-reviews-intro.ppt
June 01, 2012 - as well as scored questionnaires intended for screening or to assess likely prognosis or response to therapy … Conversely, most treatments lead directly to intended results or adverse effects. … Reprinted with corrections and an updated topical bibliography in 1988 (Los Altos, CA: Peninsula Publishing … It has proven useful for evaluating therapies and can also be applied to the evaluation of medical tests … Reprinted in 1988 with corrections and an updated topical bibliography (Los Altos, CA: Peninsula Publishing
-
effectivehealthcare.ahrq.gov/sites/default/files/medical-test-reviews-intro.ppt
June 01, 2012 - as well as scored questionnaires intended for screening or to assess likely prognosis or response to therapy … Conversely, most treatments lead directly to intended results or adverse effects. … Reprinted with corrections and an updated topical bibliography in 1988 (Los Altos, CA: Peninsula Publishing … It has proven useful for evaluating therapies and can also be applied to the evaluation of medical tests … Reprinted in 1988 with corrections and an updated topical bibliography (Los Altos, CA: Peninsula Publishing
-
effectivehealthcare.ahrq.gov/sites/default/files/topic-refinement.ppt
March 01, 2010 - Beliefs about the advantages or disadvantages of various alternative treatments are an important target … , another active therapy, or no control therapy
O — Pulmonary variables, anthropometrics, bone variables … Control therapies we would accept were placebo, no therapy, another active therapy, or no control therapy … duration, baseline nutritional status, and concurrent medical therapies? … duration, baseline nutritional status, and concurrent medical therapies?
-
effectivehealthcare.ahrq.gov/sites/default/files/06_devdelays_potential_high_impact_2012-12-10.pdf
January 01, 2012 - new (and new uses of existing) pharmaceuticals, medical devices,
diagnostic tests and procedures, therapeutic … , screening and diagnostics, therapeutics, surgery, programs, and care
delivery innovations that address … Early-intervention treatment includes behavior and communication therapies (including
applied behavior … archived from the horizon scanning system
after expert comment processes include hyperbaric oxygen therapy … STX209 (arbaclofen, Seaside Therapeutics, Cambridge,
MA) is a gamma aminobutyric acid (GABA)-B agonist
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0316_03-12-2009.pdf
January 01, 2009 - It can also be used to adjust anti-hypertensive drug therapy and reduce clinic visits
with patients. … What is the effect of treatment guided by SMBP in comparison to treatment guided by
clinic BP, in terms … Use of anti-hypertensive drug therapy
iv. BP control
3. … What is the effect of treatment guided by ABP in comparison to treatment guided by clinic BP,
in terms … Use of anti-hypertensive drug therapy
iv. BP control
4.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/episodic-migraine-surveillance-report-2.pdf
June 01, 2022 - Acute Treatment for Episodic Migraine: Surveillance Report 2
Acute Treatments for Episodic Migraine … , usual care, attention control, and no treatment up to 4 weeks after
treatments (KQ 3). … What are the effects of prescribing opioid therapy versus not
prescribing opioid therapy for acute treatment … invasive
treatments (surgical
interventions, etc.),
and preventive
(prophylactic)
treatment … , nonpharmacologic
therapy
KQ3: Sham treatment, waitlist, usual care, attention control, and no
treatment